Comparing treatments for persistent atrial fibrillation
Part of Heart & circulation clinical trials.
This study compares two treatments for persistent atrial fibrillation (AF) that lasts more than 7 days but less than 2 years: electrical cardioversion (a shock to reset your heart rhythm) versus catheter ablation (using radio waves to fix the heart's electrical pathways). It aims to find which option works better for patients like you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old.
- You have atrial fibrillation that has lasted continuously for more than 7 days but less than 2 years.
- Your doctor has already talked to you about having a cardioversion.
- You must be willing and able to take blood thinners (anticoagulation) to prevent clots.
- Your kidneys are working well (eGFR above 30).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a catheter ablation procedure for people with persistent atrial fibrillation (a type of irregular heartbeat that lasts more than 7 days but less than a year). It aims to see if the procedure is safe and effective for restoring a normal heart rhythm.
This trial tests a newer, possibly safer way to treat persistent atrial fibrillation using pulsed field ablation. It compares standard vein isolation alone to adding extra ablation spots to improve success.
This trial tests whether adding extra ablation lines to the standard pulmonary vein isolation procedure is more effective for people with persistent atrial fibrillation that hasn't been helped by medications. The goal is to improve symptoms like palpitations, fatigue, and shortness of breath.
This trial tests a new type of ablation (pulsed-field) to treat persistent atrial fibrillation (AFib) that lasts more than 7 days. You may qualify if you have symptoms and haven't had other heart ablation procedures except for one specific type.
This trial tests whether blocking faulty heart signals from the pulmonary veins (with or without additional “substrate” modification) works better when electric cardioversion doesn’t stop persistent atrial fibrillation. It may help people who remain in atrial fibrillation after cardioversion by reducing symptoms and abnormal rhythm over time.
This study tests whether adding a modification to a standard heart procedure (pulmonary vein isolation) works better for people with persistent atrial fibrillation (a type of irregular heartbeat that lasts a long time). It may help find the best way to treat this condition.
Hear when a new Persistent Atrial Fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.